Q3 2020 ADC Therapeutics SA Earnings Call Transcript
Thank you for holding. Good morning, and welcome to ADC Therapeutics Third Quarter 2020 Financial and Operating Results Call.
(Operator Instructions) Please be advised that this call is being recorded at the company's request.
At this time, I'd like to turn it over to Amanda Hamilton, Investor Relations Manager at ADC Therapeutics. Please proceed.
Thank you, operator. This morning, we issued a press release announcing our third quarter 2020 financial results and business updates. This release is available on the ADCT website at ir.adctherapeutics.com under the Press Releases section.
On today's call, Chris Martin, Chief Executive Officer; Jay Feingold, Chief Medical Officer; and Jen Creel, Chief Financial Officer, will discuss recent business highlights and review our third quarter 2020 financial results. In addition, Jennifer Herron, our Chief Commercial Officer, will be available for questions.
As a reminder, this conference call may contain statements that constitute
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |